Ranbaxy’s Ripples: Generic Drug Integrity Returns As Focus For Congress, FDA

Problems at a drug company have once again put FDA in the crosshairs of the House Energy and Commerce Committee

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet